Cannabis for Medicinal Use
Dail Éireann — 2024-05-02
============================================================

Gino Kenny (PBP), Dublin Mid-West

I understand the appeal of licensed products, but the MCAP was set up for those who have tried every known medication for their condition and they want to be in a position where they could try a number of these other medications. I think nine medical cannabis products are listed, which is better than it was perhaps 18 months ago, but there is enormous frustration with the restrictions and limitations of the MCAP, under which medication can only be prescribed by a consultant. The number of medical professionals in this field is very limited. Another limitation is that it is confined to the three conditions. If MCAP does not expand, I do not see where the programme will go. The Danish medical cannabis access programme has a number of conditions where the evidence for the use of medical cannabis, in particular relating to neuropathic pain, is very good.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2024-05-02/debate/main
Retrieved: 2026-08-14T04:52:54+00:00
Sitting date: 2024-05-02